Time-limited triplet therapy in relapsed/refractory CLL; patient-reported outcomes in chronic GVHD-related sclerosis; myeloid bias mechanisms in hematopoiesis
This episode covers time-limited triplet therapy for relapsed or refractory CLL, showing deep remissions and good tolerance. It also discusses a new patient-reported outcome measure for chronic GVHD-related sclerosis and explores the mathematical modeling of myeloid bias in…